Edentulous
Conditions
Keywords
dental implants
Brief summary
The aim of this study is to evaluate the effect of abutment macro-design on soft and hard tissue responses. This trial is designed as a randomized controlled clinical study in which two groups of fourteen partially edentulous patients will have as part of their treatment one implant placed in the maxillary premolar region.
Detailed description
Implant placement and abutment design will be planned with a computer software for guided implant treatment (SIMPLANT). The surgical implant placement will be performed under manufacturer's protocol by placing the implant platform 1mm below the buccal aspect of the osteotomy (Koutouzis et al 2013). Virtually designed, permanent CAD-CAM fabricated abutments (ATLANTIS, DENTSPLY) with different configuration of the subcritical contour (emergence shape) will be connected to the implants and temporary crowns will be delivered. Implants of the Group 1 will have permanent abutments with a concave configuration of the subcritical contour (emergence shape). Implants of the Group 2 will have permanent abutments with a convex configuration of the subcritical contour (emergence shape). The patients will be restored with single crowns 3 months following implant installation. A randomization protocol will be produced from a computer-generated list for the distribution of subjects in the two treatment groups.
Interventions
Implants will be restored with abutments with concave configuration of the subcritical contour
Implants will be restored with abutments with convex configuration of the subcritical contour
Sponsors
Study design
Eligibility
Inclusion criteria
General Inclusion criteria: * \- Age more than 21 years * Absence of relevant medical conditions * Availability for 12 month follow-up Specific Inclusion criteria: * One missing tooth in the maxillary premolar region * Presence of two adjacent teeth at the implant site * Absence of periodontal disease * Healed osseous architecture enough to receive an implant with a diameter of at least 3.5 mm and a sufficient amount of bone for placing implants with a length of at least 9 mm General
Exclusion criteria
* \- Pregnancy at the screening visit. * Smoking more than 10 cig/day Specific
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Peri-implant mucosa margin position change | Day 7-10 to the Day 360 | The primary outcome variable will be change on peri-implant mucosa margin position. |
Countries
United States